News Drug firms have to pay $162m in damages over hepatitis C infection BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d7103 (Published 01 November 2011) Cite this as: BMJ 2011;343:d7103 Article Related content Metrics Responses Peer review Related articles News Doctors call for ban on multidose vials after hepatitis C outbreak in US Published: 27 July 2010; BMJ 341 doi:10.1136/bmj.c4057 News In brief Published: 13 March 2012; BMJ 344 doi:10.1136/bmj.e2018 See more Individual care plans reduce falls and broken hips in New Zealand hospitals BMJ December 05, 2016, 355 i6490; DOI: https://doi.org/10.1136/bmj.i6490 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Workloads threaten to undermine doctors’ training, GMC finds BMJ December 01, 2016, 355 i6495; DOI: https://doi.org/10.1136/bmj.i6495 Junior doctors’ low morale is putting patients at risk, Royal College of Physicians warns BMJ December 01, 2016, 355 i6493; DOI: https://doi.org/10.1136/bmj.i6493 Funds are not reaching frontline services BMJ November 28, 2016, 355 i6273; DOI: https://doi.org/10.1136/bmj.i6273